Business Context and Reporting Period
This Form 8-K is a current report filed by Herbalife Nutrition Ltd. on October 23, 2019, with the earliest event reported on that date. The filing primarily addresses executive leadership transitions and references the company's financial results for the fiscal quarter ended September 30, 2019, which were announced via a press release on October 29, 2019.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained in the press release attached as Exhibit 99.1, which is incorporated by reference but not detailed within the body of this 8-K document.
Material Changes and Executive Transition
The most significant material change reported is the appointment of new executive leadership, effective March 30, 2020:
- Chief Executive Officer: Dr. John Agwunobi (currently Co-President and Chief Health and Nutrition Officer) will succeed Michael Johnson. Dr. Agwunobi will receive an annual base salary of $900,000 and a target annual bonus of 115% of base salary.
- President: John DeSimone (currently Co-President and Chief Strategic Officer) will assume the role of President. Mr. DeSimone will receive an annual base salary of $695,000 and a target annual bonus of 80% of base salary.
- Outgoing CEO: Michael Johnson will step down as CEO but will continue to serve as Chairman of the Board.
Compensation, Equity, and Severance Arrangements
New employment agreements were executed on October 23, 2019, detailing the following compensation structures for the incoming executives:
- Equity Incentives (2020):
- Dr. Agwunobi: Grant date fair value of $3,500,000 (75% performance-based stock units, 25% time-based stock units).
- Mr. DeSimone: Grant date fair value of $2,250,000 (75% performance-based stock units, 25% time-based stock units).
- Severance Plan: Both executives are covered under the Executive Officer Severance Plan. In the event of termination without "Cause" or for "Good Reason":
- CEO Severance: 2.0x annualized base salary (reduced to 1.5x after five years of participation).
- President Severance: 1.0x annualized base salary.
- Both receive pro-rata annual cash bonuses based on actual performance and days worked.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated October 29, 2019) for specific Q3 2019 financial results, as this 8-K does not contain the data.
- Verify the performance criteria for the 75% performance-based stock units granted to Dr. Agwunobi and Mr. DeSimone.
- Confirm the exact terms of the "Cause" and "Good Reason" definitions within the Severance Plan to understand termination triggers.
- Monitor the transition timeline to ensure the effective date of March 30, 2020, is met without disruption.